The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
NSF's Tech Accelerators Aim to Bridge the 'Valley of Death'
The agency aims to connect researchers with investors to bring emerging technologies in specific areas to market faster.
2m read -
USPIS Uses AI to Advance Criminal Investigations
The U.S. Postal Inspection Service is using AI to uncover crime patterns, support investigations and improve workforce efficiency.
5m watch -
Advice for the Next Generation of Cybersecurity Professionals
Author Agathe Merle discussed breaking barriers in cybersecurity, fostering inclusion and using creativity to strengthen cyber defense.
29m watch -
How Army Contracting Command is Using AI in Acquisition
Army Contracting Command’s Jordan Duke discusses AI adoption, cybersecurity risks and securing acquisition operations across the Army enterprise.
9m listen
